Loading
Albumin-Globulin Ratio Predicts Bladder Cancer Survival

The pretreatment albumin-globulin ratio can independently predict survival outcomes in patients with urothelial carcinoma, according to a recent meta-analysis. Zhongyou Xia of the Nanchong Central Hospital, The Second Clinical College, North Sichuan Medical College, and colleagues conducted the analysis and published its results in Frontiers in Oncology. ...

Advertisement

Latest News

Advertisement
Advertisement
Editorial Advisory Board

Knowledge Hubs

Curated clinical content based on conditions, therapies, and technologies

Prostate Cancer
Prostate Cancer

Conference Coverage

Live meeting highlights

Leah Lawrence

ESMO 2022 | September 16, 2022

A new study has found an association between neurodevelopmental disorders and testicular seminoma.

Leah Lawrence

ESMO 2022 | September 16, 2022

CLEAR study results showed that treatment with first-line lenvatinib plus pembrolizumab had clinical benefit at 2 years.

Leah Lawrence

ESMO 2022 | September 16, 2022

The RACE IT trial finds neoadjuvant radio-immunotherapy followed by radical cystectomy a safe and feasible treatment option.

Patrick Daly

ESMO 2022 | September 14, 2022

Patients with mCRPC with AR alterations had significantly worse survival outcomes compared with patients with wild-type.

The Uromigos

Podcasts hosted by Professors Thomas Powles, MD, and Brian Rini, MD

Roundtables

Clinical discussions with experts in the field

Journal

Articles from the GU Oncology Now Journal